MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,057,700 | -36.2% | 123,649 | +0.9% | 0.00% | -40.0% |
| Q2 2023 | $28,320,369 | +3.0% | 122,599 | +8.0% | 0.01% | 0.0% |
| Q1 2023 | $27,492,876 | -15.0% | 113,485 | +1.8% | 0.01% | -28.6% |
| Q4 2022 | $32,360,844 | +339.1% | 111,493 | -1.7% | 0.01% | +250.0% |
| Q3 2022 | $7,370,000 | -10.5% | 113,405 | -1.4% | 0.00% | 0.0% |
| Q2 2022 | $8,231,000 | -24.7% | 114,995 | +3.2% | 0.00% | 0.0% |
| Q1 2022 | $10,930,000 | +10.3% | 111,402 | -4.7% | 0.00% | 0.0% |
| Q4 2021 | $9,908,000 | +10.8% | 116,930 | +4.4% | 0.00% | 0.0% |
| Q3 2021 | $8,939,000 | -20.1% | 112,047 | -2.5% | 0.00% | 0.0% |
| Q2 2021 | $11,188,000 | -4.9% | 114,862 | +14.2% | 0.00% | 0.0% |
| Q1 2021 | $11,765,000 | +1.7% | 100,578 | -3.3% | 0.00% | 0.0% |
| Q4 2020 | $11,563,000 | -8.0% | 104,023 | -1.8% | 0.00% | -33.3% |
| Q3 2020 | $12,571,000 | -1.9% | 105,880 | -6.4% | 0.00% | 0.0% |
| Q2 2020 | $12,809,000 | +72.6% | 113,108 | +1.7% | 0.00% | +50.0% |
| Q1 2020 | $7,422,000 | -14.9% | 111,176 | +16.1% | 0.00% | 0.0% |
| Q4 2019 | $8,722,000 | -3.4% | 95,725 | -8.6% | 0.00% | 0.0% |
| Q3 2019 | $9,027,000 | -12.5% | 104,687 | +6.4% | 0.00% | 0.0% |
| Q2 2019 | $10,314,000 | -14.5% | 98,407 | +2.2% | 0.00% | -33.3% |
| Q1 2019 | $12,059,000 | +12.6% | 96,271 | +1.3% | 0.00% | 0.0% |
| Q4 2018 | $10,711,000 | -51.4% | 95,024 | -7.6% | 0.00% | -40.0% |
| Q3 2018 | $22,019,000 | -13.2% | 102,828 | +13.4% | 0.01% | -16.7% |
| Q2 2018 | $25,358,000 | +194.9% | 90,663 | +23.1% | 0.01% | +200.0% |
| Q1 2018 | $8,600,000 | +43.6% | 73,640 | +12.9% | 0.00% | 0.0% |
| Q4 2017 | $5,989,000 | +152.3% | 65,247 | +23.6% | 0.00% | +100.0% |
| Q3 2017 | $2,374,000 | +191.6% | 52,796 | +5.4% | 0.00% | – |
| Q2 2017 | $814,000 | +166.0% | 50,069 | +151.2% | 0.00% | – |
| Q1 2017 | $306,000 | – | 19,935 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |